| Article | Date | Source |
|---|
| TetraLogic Pharmaceuticals Announces Decision to Grant Japanese Patent on Birinapant | January 29, 2013 | Pharma News - PharmiWeb |
| TetraLogic Pharmaceuticals Granted Third U.S. Patent on Birinapant | October 09, 2012 | Pharma News - Business Wire |
| TetraLogic Pharmaceuticals Founder John Gill Receives Semper Fidelis Award | April 23, 2012 | Pharma News - Business Wire |
| TetraLogic Pharmaceuticals Announces Presentation of Preclinical Data on Birinapant (TL32711) in Pancreatic Cancer and Lymphoma at the 103rd AACR Annual Meeting 2012 | April 03, 2012 | Pharma News - Business Wire |
| TetraLogic Pharmaceuticals Announces Oral Presentation on Smac Mimetic TL32711 at American Society of Hematology (ASH) Annual Meeting | December 12, 2011 | Biotech News - PR Newswire |
| TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML) | December 05, 2011 | Biotech News - PR Newswire |
| TetraLogic Pharmaceuticals Announces Presentation of Data on Smac Mimetic TL32711 at AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics | November 13, 2011 | Biotech News - PR Newswire |
| TetraLogic Pharmaceuticals, Inc.: Series C $6M | July 28, 2011 | OnBioVC |
| TetraLogic Appoints Jonathan B. Lloyd Jones as Chief Financial Officer and Vice President Corporate Development | June 08, 2011 | Pharma News - PR Newswire |
| TetraLogic gets $6M from Swiss investor Nextech | May 24, 2011 | Health News - BizJournals.com |
| TetraLogic Pharmaceuticals Closes $6 Million Series C-1 Investment with | May 24, 2011 | BioSpace - Breaking News |
| TetraLogic Closes $6 Million Series C-1 Investment with Nextech Invest Ltd. | May 24, 2011 | Biotech News - PR Newswire |
| TetraLogic Pharmaceuticals, Inc.: Series C $23M | May 20, 2011 | OnBioVC |
| TetraLogic Pharmaceuticals Closes $23 Million Second Tranche of Series C Financing | January 05, 2011 | BioSpace |
| TetraLogic Closes $23 Million Second Tranche of Series C Financing | January 05, 2011 | Pharma News - PR Newswire |
| TetraLogic Pharmaceuticals, Inc.: Series C $5M | October 04, 2010 | OnBioVC |
| TetraLogic Pharmaceuticals Expands Series C Financing with New Investor with Investment of $5 Million Increasing Total Series C Financing to $32 Million | September 28, 2010 | BioSpace |
| TetraLogic Pharmaceuticals Expands Series C Financing with New Investor with Investment of $5 Million Incrasing Total Series C Financing to $32 Million | September 28, 2010 | BioSpace |
| TetraLogic pushes Series C to $37M | September 28, 2010 | FierceBiotech |
| TetraLogic Expands Series C Financing with New Investor Pfizer Ventures | September 27, 2010 | Pharma News - Business Wire |
| Company Profile for TetraLogic Pharmaceuticals | September 24, 2010 | Pharma News - Business Wire |
| TetraLogic Pharmaceuticals, Inc.: Series C $32M | August 19, 2010 | OnBioVC |
| TetraLogic Pharmaceuticals of Malvern raises $32M in stock sale | August 10, 2010 | Health News - BizJournals.com |
| TetraLogic nabs $32M round for lead cancer therapy | August 10, 2010 | FierceBiotech |
| TetraLogic Pharmaceuticals Completes $32 Million Series C Financing | August 10, 2010 | Pharma News - Business Wire |
| TetraLogic Pharmaceuticals Initiates Phase 1 Clinical Trial of TL32711 in Patients with Refractory Solid Tumors or Lymphoma | January 08, 2010 | Pharma News - Business Wire |
